The PPGL market is advancing through precision medicine and targeted therapy innovations. Key players including Progenics, Lexicon, and RayzeBio are developing novel radiotherapeutics and genetic-based treatments that enhance tumor control and reduce recurrence rates. Evolving diagnostic biomarkers and multidisciplinary care approaches are optimizing management strategies for these rare catecholamine-secreting tumors.
Access Market Report: https://shorturl.at/UNpYz
Мне нравится
Комментарий
Перепост
